Appendix A
Workshop Agenda
Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development
July 22, 2010
The Keck Center, Room 100
500 Fifth Street, N.W.
Washington, DC 20001
MEETING OBJECTIVE
To explore relevant issues related to developing a cultural, legal, and behavioral framework of collaboration that enables biospecimen and data sharing.
-
What are the critical factors necessary for a successful collaboration?
-
What lessons can be learned from existing collaborations?
-
What are the challenges that exist and potential ways to overcome them?
8:00-9:00 A.M. |
WORKING BREAKFAST |
9:00 A.M. |
PUBLIC WORKSHOP BEGINS |
9:00-9:10 A.M. |
Welcome and Introductory Remarks |
|
Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University |
9:10-9:55 A.M. |
EXTENDING THE SPECTRUM OF PRECOMPETITIVE ONCOLOGY BIOMEDICAL RESEARCH: A SUMMARY |
|
Moderator: Martha Turner, American Nurses Association |
9:10-9:35 A.M. |
Lessons Learned |
|
Stephen Friend, President and Chief Executive Officer (CEO), Sage Bionetworks |
9:35-9:55 A.M. |
Discussion |
9:55-11:30 A.M. |
REQUISITES FOR SUCCESSFUL PRECOMPETITIVE COLLABORATION |
|
Moderator: Sharon Terry, Genetic Alliance |
9:55-10:15 A.M. |
The Architecture of Collaboration |
|
William J. Spencer, Chairman Emeritus, SEMATECH |
10:15-10:35 A.M. |
Requisites from the Pharmaceutical Industry |
|
Aidan Power, Vice President and Global Head of Molecular Medicine, Pfizer Inc. |
10:35-10:50 A.M. |
BREAK |
10:50-11:10 A.M. |
Requisites from Diagnostic Companies |
|
Marcia Eisenberg, Senior Vice President, LabCorp |
11:10-11:30 A.M. |
Requisites from Academia |
|
Neal Cohen, Vice Dean, School of Medicine, Professor of Anesthesia and Perioperative Care and Medicine, Director of International Medical Services, University of California, San Francisco |
11:30 A.M.-12:30 P.M. |
WORKING LUNCH |
12:30-2:05 P.M. |
FRAMEWORK OF COLLABORATIONS WITH THE PHARMACEUTICAL INDUSTRY |
|
Moderator: Aidan Power, Pfizer Inc. |
12:30-12:50 P.M. |
Public–Private Partnerships with NIH or Government |
|
Thomas Insel, Director of the National Institute of Mental Health, National Institutes of Health |
12:50-1:10 P.M. |
Advancing Technological Achievements Through Collaboration |
|
Christopher Beecher, Research Professor, Michigan Center for Translational Pathology, University of Michigan |
1:10-1:30 P.M. |
Open Access Partnerships |
|
Aled Edwards, Director and CEO, Structural Genomics Consortium; Professor, Department of Medical Biophysics, University of Toronto |
1:30-1:50 P.M. |
Access to Large-Scale Data Networks |
|
Stephen Friend, President and CEO, Sage Bionetworks |
1:50-2:05 P.M. |
BREAK |
2:05-4:05 P.M. |
BIOSPECIMENS |
|
Moderator: Geoffrey Ginsburg, Duke University |
2:05-2:25 P.M. |
Sustaining Access to Biospecimens |
|
Martin Yuille, Reader in Biobanking, Co-director, Centre for Integrated Genomic Medical Research, University of Manchester |
2:25-2:45 P.M. |
Developing Common Biorepository Infrastructures |
|
Carolyn Compton, Director, Office of Biorepositories and Biospecimen Research, National Cancer Institute |
2:45-3:05 P.M. |
Linking Health Outcomes Data to Biorepository Samples |
|
Cynthia Helphingstine, President and CEO, Fairbanks Institute for Healthy Communities |
3:05-3:25 P.M. |
Creating a National Virtual Biospecimen Bank |
|
Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston |
3:25-3:45 P.M. |
Opportunities and Challenges of Clinical and Genetic Data Access in the Pharmaceutical Industry |
|
Sally John, Head of Human Genetics, Molecular Medicine, PharmaTherapeutics Research, Pfizer Inc. |
3:45-4:05 P.M. |
Ethical Challenges for Biospecimen and Data Sharing |
|
Ellen Wright Clayton, Rosalind E. Franklin Professor of Genetics and Health Policy; Director, Center for Biomedical Ethics and Society, Vanderbilt University |
4:05-5:05 P.M. |
PANEL DISCUSSION |
4:05 - 5:05 P.M. |
Developing a cultural, legal, and behavioral framework of collaboration that enables resource sharing in order to accelerate genomics-based drug and diagnostic product development |
|
Moderator: Stephen Eck, Eli Lilly and Company |
|
Panelists: |
|
Ellen Wright Clayton, Rosalind E. Franklin Professor of Genetics and Health Policy; Director, Center for Biomedical Ethics and Society, Vanderbilt University |
|
Kelly Edwards, Associate Professor, Department of Bioethics and Humanities, University of Washington School of Medicine Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University Garry Neil, Corporate Vice President, COSAT, Johnson & Johnson William J. Spencer, Chairman Emeritus, SEMATECH Sharon Terry, President and CEO, Genetic Alliance |
5:05-5:30 P.M. |
SUMMARY AND CONCLUSIONS |
|
Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University Stephen Eck, Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly and Company Aidan Power, Vice President and Global Head of Molecular Medicine, Pfizer Inc. Sharon Terry, President and CEO, Genetic Alliance |